Zinzino group revenue increased with a total of 1% in Q2, compared with the previous year.

The revenue in June for Zinzino's sales markets increased by 2% and amounted to SEK 104.7 (102.8) million. Faun Pharma's external sales increased by 100% and amounted to SEK 8.0 (4.0) million. Overall, the Group increased revenues by 6% to SEK 112.7 (106.8) million compared with the previous year.

Sales in Zinzino's sales markets were unchanged in the second quarter of 2022 compared with the same period last year and amounted to SEK 306.1 (306.4) million. Total revenues in the Group increased by 1% in the second quarter and amounted to SEK 326.7 (322.4) million.

Accumulated revenue for January - June 2022 increased by 1% compared with the same period last year and amounted to SEK 661.1 (655.8) million.

Revenues were distributed as follows:

Regions, mSEK22-Jun21-JunChangeQ2 2022Q2 2021ChangeYTD 2022YTD 2021Change
The Nordics 24.3 32.3 -25% 75.8 92.8 -18% 156.1 186.6 -16%
Central Europe 24.1 19.3 25% 64.5 53.9 20% 123.6 107.9 15%
East Europe 24.3 23.7 3% 76.6 79.4 -4% 160.0 160.5 0%
South & West Europe 12.9 12.6 2% 36.5 37.0 -1% 74.6 70.5 6%
The Baltics 5.2 5.1 2% 16.3 16.8 -3% 34.6 35.6 -3%
North America 7.5 4.2 79% 18.1 10.5 72% 32.2 25.1 28%
Asia-Pacific 5.7 5.6 2% 16.5 16.0 3% 32.9 36.2 -9%
Africa 0.7 0.01.8 0.03.2 0.0
Zinzino104.7102.82%306.1306.40%617.2622.4-1%
Faun Pharma 8.0 4.0 100% 20.6 16.0 29% 43.9 33.4 31%
Zinzino Group112.7106.86%326.7322.41%661.1655.81%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:00 the 5th of July 2022.

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q2-2022,c3596926

https://mb.cision.com/Main/10976/3596926/1601256.pdf

(c) 2022 Cision. All rights reserved., source Press Releases - English